SARS-CoV-2 curtails immune response in the gut

by European Molecular Biology LaboratoryThe researchers were able to monitor the virus's growth in organoids derived from human intestinal cells. Pink and red show areas of SARS-CoV-2 infecti

Updated on: April 22,2024

SARS-CoV-2 curtails immune response in the gut

by European Molecular Biology LaboratoryThe researchers were able to monitor the virus's growth in organoids derived from human intestinal cells. Pink and red show areas of SARS-CoV-2 infecti

Updated on:April 22,2024

Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses

by University of Alabama at BirminghamCredit: University of Alabama at BirminghamPreclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show positive resul

Updated on: April 10,2024

Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses

by University of Alabama at BirminghamCredit: University of Alabama at BirminghamPreclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show positive resul

Updated on:April 10,2024

Novel mechanism of ILC2 immune cell development may be involved in exacerbating allergic diseases

byChiba UniversityResearchers identify a G3SE-dependent mechanism of ILC2 development. Credit: Yosuke Toda and Arifumi Iwata from Chiba UniversityOverproduction of Group 2 innate lymphoid cells

Updated on: July 11,2024

Novel mechanism of ILC2 immune cell development may be involved in exacerbating allergic diseases

byChiba UniversityResearchers identify a G3SE-dependent mechanism of ILC2 development. Credit: Yosuke Toda and Arifumi Iwata from Chiba UniversityOverproduction of Group 2 innate lymphoid cells

Updated on:July 11,2024

Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants

by La Jolla Institute for ImmunologyT cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-Co

Updated on: April 20,2024

Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants

by La Jolla Institute for ImmunologyT cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-Co

Updated on:April 20,2024

Smoking impairs treatment response in inflammatory back arthritis

by British Medical JournalSmoking harms nearly every organ in the body and causes many diseases. Credit: CDC/Debora CartagenaSmoking impairs the response to biological drugs used to treat inflamm

Updated on: May 13,2024

Smoking impairs treatment response in inflammatory back arthritis

by British Medical JournalSmoking harms nearly every organ in the body and causes many diseases. Credit: CDC/Debora CartagenaSmoking impairs the response to biological drugs used to treat inflamm

Updated on:May 13,2024

New device for low-cost single-cell analysis identifies fibroblast subtypes in rheumatoid arthritis patients

by New York Genome CenterResearchers at the New York Genome Center (NYGC) and New York University (NYU) have taken steps to facilitate broad access to single-cell sequencing by developing a 3-D-printe

Updated on: April 07,2024

New device for low-cost single-cell analysis identifies fibroblast subtypes in rheumatoid arthritis patients

by New York Genome CenterResearchers at the New York Genome Center (NYGC) and New York University (NYU) have taken steps to facilitate broad access to single-cell sequencing by developing a 3-D-printe

Updated on:April 07,2024

Early combined treatment with biologic and conventional DMARDs could be effective for polyarticular juvenile arthritis

by American College of RheumatologyCredit: CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, found that patients sta

Updated on: March 28,2024

Early combined treatment with biologic and conventional DMARDs could be effective for polyarticular juvenile arthritis

by American College of RheumatologyCredit: CC0 Public DomainNew research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, found that patients sta

Updated on:March 28,2024

Respiratory disease may increase risk for rheumatoid arthritis

(HealthDay)—Respiratory diseases increase the risk for rheumatoid arthritis, according to a study published online Aug. 16 inArthritis & Rheumatology.Vanessa L. Kronzer, M.D., from the Mayo

Updated on: July 02,2024

Respiratory disease may increase risk for rheumatoid arthritis

(HealthDay)—Respiratory diseases increase the risk for rheumatoid arthritis, according to a study published online Aug. 16 inArthritis & Rheumatology.Vanessa L. Kronzer, M.D., from the Mayo

Updated on:July 02,2024

Study finds gut microbiota influence severity of respiratory viral infection

by Georgia State UniversityThis picture illustrates an example of gut microbiota composition dictating how resident lung alveolar macrophages (AM) respond to viral infection. The presence of segm

Updated on: March 07,2024

Study finds gut microbiota influence severity of respiratory viral infection

by Georgia State UniversityThis picture illustrates an example of gut microbiota composition dictating how resident lung alveolar macrophages (AM) respond to viral infection. The presence of segm

Updated on:March 07,2024

New juvenile idiopathic arthritis guideline emphasizes disease-modifying treatments

by American College of RheumatologyCredit: CC0 Public DomainThe American College of Rheumatology (ACR) will preview the 2021 Guideline for the Treatment of Juvenile Idiopathic Arthritis at ACR Co

Updated on: May 08,2024

New juvenile idiopathic arthritis guideline emphasizes disease-modifying treatments

by American College of RheumatologyCredit: CC0 Public DomainThe American College of Rheumatology (ACR) will preview the 2021 Guideline for the Treatment of Juvenile Idiopathic Arthritis at ACR Co

Updated on:May 08,2024

Biomarkers may ID rheumatoid arthritis patients with and without active disease

Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) values may differentiate between rheumatoid arthritis (RA) patients with and without active disease, according to a systemat

Updated on: May 29,2024

Biomarkers may ID rheumatoid arthritis patients with and without active disease

Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) values may differentiate between rheumatoid arthritis (RA) patients with and without active disease, according to a systemat

Updated on:May 29,2024

Lower RA activity for patients seen at practices with NPs, PAs

(HealthDay)—Patients with rheumatoid arthritis (RA) have lower disease activity when seen at practices with nurse practitioners (NPs) or physician assistants (PAs) versus rheumatologist-only practices

Updated on: March 24,2024

Lower RA activity for patients seen at practices with NPs, PAs

(HealthDay)—Patients with rheumatoid arthritis (RA) have lower disease activity when seen at practices with nurse practitioners (NPs) or physician assistants (PAs) versus rheumatologist-only practices

Updated on:March 24,2024